Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS
Content archived on 2024-05-27

Role of peroxisome proliferator-activated receptors (ppars) in neurodegenerative disease.

Objective

Area of Research Training The principal aims of this proposal is to gain an understanding of the role of peroxisome proliferator-activated receptors (PPARs) in neurodegenerative disease. Since these molecules have been implicated in a multitude of neurodegenerative and neuro inflammatory diseases, and recent work has suggested a protective role for PPAR activation in Alzheimer's disease and Multiple Sclerosis, we now wish to investigate and understand the mechanisms involved in mediating these events. You will work in multi skilled team environment and gain extensive experience in a number of techniques including neuronal cell biology, primary cell culture and models of neurod generation. The work environment You will be based at our impressive new £250 million, science complex at New Frontiers Science Park, Harlow, UK which provides access to a leading edge facility incorporating state of the art equipment and dedicated teams of support services that provide researchers with an atmosphere totally committed to pioneering research. For more information on GlaxoSmithKline, visit our website at www.gsk.com Qualification/Expertise Required by the Applicants A PhD in Cell Biology or Neurobiology is required. Experience in molecular biology is essential. You should have a flexible working approach, good interpersonal skills and be able to work effectively in a team environment.

Fields of science (EuroSciVoc)

Topic(s)

Data not available

Call for proposal

Data not available

Funding Scheme

BUR - Bursaries, grants, fellowships

Coordinator

GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LIMITED
EU contribution
No data
Address
Great West Road 980
TW8 9GS BRENTFORD
United Kingdom
Total cost
No data